114 related articles for article (PubMed ID: 8173961)
21. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
Cragg S; Rice ME; Greenfield SA
J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
[TBL] [Abstract][Full Text] [Related]
23. Role of dynorphin and GABA in the inhibitory regulation of NMDA-induced dopamine release in striosome- and matrix-enriched areas of the rat striatum.
Krebs MO; Gauchy C; Desban M; Glowinski J; Kemel ML
J Neurosci; 1994 Apr; 14(4):2435-43. PubMed ID: 7908960
[TBL] [Abstract][Full Text] [Related]
24. Excitatory amino acid-induced excitation of dopamine-containing neurons in the rat substantia nigra: modulation by kynurenic acid.
Wu HQ; Schwarcz R; Shepard PD
Synapse; 1994 Mar; 16(3):219-30. PubMed ID: 7515199
[TBL] [Abstract][Full Text] [Related]
25. Local GABAergic regulation of the N-methyl-D-aspartate-evoked release of dopamine is more prominent in striosomes than in matrix of the rat striatum.
Krebs MO; Kemel ML; Gauchy C; Desban M; Glowinski J
Neuroscience; 1993 Nov; 57(2):249-60. PubMed ID: 8115037
[TBL] [Abstract][Full Text] [Related]
26. Dopamine action in the substantia nigra pars reticulata: iontophoretic studies in awake, unrestrained rats.
Windels F; Kiyatkin EA
Eur J Neurosci; 2006 Sep; 24(5):1385-94. PubMed ID: 16987223
[TBL] [Abstract][Full Text] [Related]
27. MK-801 interaction with the 5-HT transporter: a real-time study in brain slices using fast cyclic voltammetry.
Iravani MM; Muscat R; Kruk ZL
Synapse; 1999 Jun; 32(3):212-24. PubMed ID: 10340631
[TBL] [Abstract][Full Text] [Related]
28. Effects of peripheral and local administration of picrotoxin on the release of newly synthesized 3H-dopamine in the caudate nucleus of the cat.
Cheramy A; Nieoullon A; Glowinski J
Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):31-7. PubMed ID: 870831
[TBL] [Abstract][Full Text] [Related]
29. Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate.
Kamal LA; Arbilla S; Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1983 Nov; 227(2):446-58. PubMed ID: 6631724
[TBL] [Abstract][Full Text] [Related]
30. Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum.
Krebs MO; Trovero F; Desban M; Gauchy C; Glowinski J; Kemel ML
J Neurosci; 1991 May; 11(5):1256-62. PubMed ID: 1851217
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory and potentiating influences of glycine on N-methyl-D-aspartate-evoked dopamine release from cultured rat mesencephalic cells.
Mount H; Quirion R; Chaudieu I; Boksa P
Mol Pharmacol; 1991 Feb; 39(2):205-10. PubMed ID: 1825345
[TBL] [Abstract][Full Text] [Related]
32. Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse.
Bernardini GL; Gu X; Viscardi E; German DC
J Neural Transm Gen Sect; 1991; 84(3):183-93. PubMed ID: 1679335
[TBL] [Abstract][Full Text] [Related]
33. Effects of the unilateral nigral application of dopaminergic drugs on the in vivo release of dopamine in the two caudate nuclei of the cat.
Nieoullon A; Cheramy A; Leviel V; Glowinski J
Eur J Pharmacol; 1979 Jan; 53(3):289-96. PubMed ID: 32060
[TBL] [Abstract][Full Text] [Related]
34. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin.
Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J
Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027
[TBL] [Abstract][Full Text] [Related]
35. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
[TBL] [Abstract][Full Text] [Related]
36. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
[TBL] [Abstract][Full Text] [Related]
37. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.
Bustos G; Abarca J; Campusano J; Bustos V; Noriega V; Aliaga E
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):126-44. PubMed ID: 15572168
[TBL] [Abstract][Full Text] [Related]
38. Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones.
Jones S; Gibb AJ
J Physiol; 2005 Nov; 569(Pt 1):209-21. PubMed ID: 16141268
[TBL] [Abstract][Full Text] [Related]
39. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release.
Chen BT; Moran KA; Avshalumov MV; Rice ME
J Neurochem; 2006 Feb; 96(3):645-55. PubMed ID: 16405515
[TBL] [Abstract][Full Text] [Related]
40. In vivo evidence for a dendritic release of dopamine in the cat substantia nigra.
Chéramy A; Nieoullon A; Glowinski J
Appl Neurophysiol; 1979; 42(1-2):57-9. PubMed ID: 453805
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
